Dong-a St Co., Ltd.
Clinical trials sponsored by Dong-a St Co., Ltd., explained in plain language.
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called DA 3501 in people with advanced stomach or pancreatic cancers that have a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug can shrink tumors. About 51 adults will receive the drug every three…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
Healthy volunteers needed to compare two drug versions
Knowledge-focused Recruiting nowThis early-stage study tests the safety and how the body processes two versions of an experimental drug (DA-5223 and DA-5223-R) in 12 healthy adults aged 19 to 55. Participants receive a single dose of each version in random order, and researchers measure drug levels in the blood…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 19, 2026 08:45 UTC